Trial Details

COMPLETED
Basic Information
Clinical ID c3797
Identifier NCT01517607
Trial Title Mesalazine (PENTASA®) in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions OTHER: Mesalazine
Participant Information
Sponsor Ferring Pharmaceuticals
City Altenburg
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2012-02
Primary Completion Date 2013-12
Completion Date 2013-12